Relay Pro
This study evaluates the safety and effectiveness of the RelayPro Thoracic Stent-Graft for treating acute, complicated type B aortic dissection.
About This Study
About This Study
Summary
Aortic dissection is a potentially life-threatening medical condition that results from a tear in the lining of the aorta, causing bleeding between the inner and outer layers of the aortic wall, resulting in a false channel for blood flow. Aortic dissection has traditionally been managed by antihypertensive therapy or open surgery, which are both associated with high mortality rates. The objective of this study is to investigate the safety and effectiveness of the RelayPro Thoracic Stent-Graft. This study is intended to include patients with an acute, complicated type B aortic dissection.
To be included in Relay Pro, participants must be / have
- Patients with acute, complicated type B aortic dissection eligible for treatment with the RelayPro Thoracic Stent-Graft
For More About This Study or To Ask About Participation
Additional Information
Dr. Esmaeel Reza Dadashzadeh is a dual board-certified vascular surgeon with a strong background in both clinical care and research. He’s currently the interim director of the Carilion Clinic Aortic Center and interim section chief of aortic and endovascular surgery. In addition to his clinical roles, he’s an assistant professor of aortic and endovascular surgery at Virginia Tech Carilion School of Medicine.
Dr. Dadashzadeh completed his vascular surgery fellowship at Washington University in St. Louis and his general surgery residency at the University of Pittsburgh Medical Center. He also holds a master’s in biomedical informatics from the University of Pittsburgh.
Official title of study
A Prospective, Multicenter, Non-Blinded, Non-Randomized Study of the RelayPro Thoracic Stent-Graft in Subjects With an Acute, Complicated Type B Aortic Dissection